Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer

K Ylänen, T Poutanen, P Savikurki-Heikkilä… - Journal of the American …, 2013 - jacc.org
Objectives: This study sought to examine the left ventricular (LV) and right ventricular (RV)
function and signs of focal fibrosis among long-term survivors of childhood cancer with the …

Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy

OH Toro-Salazar, E Gillan, MT O'Loughlin… - Circulation …, 2013 - Am Heart Assoc
Background—More than 50% of> 270 000 childhood cancer survivors in the United States
have been treated with anthracyclines and are therefore at risk of developing cardiotoxicity …

Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer

K Oberholzer, RP Kunz, M Dittrich… - RoFo: Fortschritte auf …, 2004 - europepmc.org
Purpose Quantification of left and right ventricular function using MRI in young cancer
patients treated with cardiotoxic anthracyclines. Materials and methods Twenty-eight …

[HTML][HTML] Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and …

EB Tham, MJ Haykowsky, K Chow, M Spavor… - Journal of …, 2013 - Elsevier
Background The late cardiotoxic effects of anthracycline chemotherapy influence morbidity
and mortality in the growing population of childhood cancer survivors. Even with lower …

Three-dimensional echocardiography and cardiac magnetic resonance imaging in the screening of long-term survivors of childhood cancer after cardiotoxic therapy

K Ylänen, A Eerola, K Vettenranta… - The American journal of …, 2014 - Elsevier
The left ventricular (LV) volumes, ejection fraction (EF), and dyssynchrony indexes for the 16
and 12 cardiac segments (Tmsv16-SD and Tmsv12-SD, respectively) were analyzed among …

Feasibility of echocardiographic techniques to detect subclinical cancer therapeutics–related cardiac dysfunction among high-dose patients when compared with …

OH Toro-Salazar, J Ferranti, R Lorenzoni… - Journal of the American …, 2016 - Elsevier
Background Cardiac magnetic resonance imaging (CMR) is the gold standard for the
quantification of global and regional myocardial function and can detect subclinical …

Effect of anthracycline therapy on myocardial function and markers of fibrotic remodelling in childhood cancer survivors

W Mawad, L Mertens, JJ Pagano… - European Heart …, 2021 - academic.oup.com
Aims Anthracyclines are a cornerstone of paediatric cancer treatment. We aimed to quantify
myocardial cardiac magnetic resonance (CMR) native T1 (NT1) and extracellular volume …

Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors

SH Armenian, SK Gelehrter, T Vase… - Clinical Cancer …, 2014 - AACR
Purpose: To examine the utility and reliability of obtaining early echocardiographic
measurements of left ventricular (LV) remodeling as well as blood biomarkers of cardiac …

Early detection of anthracycline-induced cardiotoxicity in breast cancer survivors with T2 cardiac magnetic resonance

MB Lustberg, R Reinbolt, D Addison… - Circulation …, 2019 - Am Heart Assoc
Lustberg et al; Early T2 Increase With Anthracycline Therapy frequencies for categoric
variables. One-way repeated measures ANOVA models were fit to model changes in …

Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy

K Leger, T Slone, M Lemler, D Leonard… - Pediatric blood & …, 2015 - Wiley Online Library
Background Subclinical cardiotoxicity occurs in childhood cancer survivors following
moderate and high anthracycline doses. However, less is known about the subclinical …